-
1
المؤلفون: Maartje W. Rohaan, Troels H. Borch, Joost H. van den Berg, Özcan Met, Rob Kessels, Marnix H. Geukes Foppen, Joachim Stoltenborg Granhøj, Bastiaan Nuijen, Cynthia Nijenhuis, Inge Jedema, Maaike van Zon, Saskia Scheij, Jos H. Beijnen, Marten Hansen, Carlijn Voermans, Inge M. Noringriis, Tine J. Monberg, Rikke B. Holmstroem, Lidwina D.V. Wever, Marloes van Dijk, Lindsay G. Grijpink-Ongering, Ludy H.M. Valkenet, Alejandro Torres Acosta, Matthias Karger, Jessica S.W. Borgers, Renske M.T. ten Ham, Valesca P. Retèl, Wim H. van Harten, Ferry Lalezari, Harm van Tinteren, Astrid A.M. van der Veldt, Geke A.P. Hospers, Marion A.M. Stevense-den Boer, Karijn P.M. Suijkerbuijk, Maureen J.B. Aarts, Djura Piersma, Alfons J.M. van den Eertwegh, Jan-Willem B. de Groot, Gerard Vreugdenhil, Ellen Kapiteijn, Marye J. Boers-Sonderen, W. Edward Fiets, Franchette W.P.J. van den Berkmortel, Eva Ellebaek, Lisbet R. Hölmich, Alexander C.J. van Akkooi, Winan J. van Houdt, Michel W.J.M. Wouters, Johannes V. van Thienen, Christian U. Blank, Aafke Meerveld-Eggink, Sebastian Klobuch, Sofie Wilgenhof, Ton N. Schumacher, Marco Donia, Inge Marie Svane, John B.A.G. Haanen
المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Medical Biochemistry, CCA - Cancer Treatment and Quality of Life, AII - Cancer immunology, Landsteiner Laboratory, General Internal Medicine, Health Technology & Services Research, Health Technology Assessment (HTA), Medical Oncology, Erasmus MC other, Surgery, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy
المصدر: New England Journal of Medicine, 387(23), 2113-2125. MASSACHUSETTS MEDICAL SOC
The New England Journal of Medicine, 387, 2113-2125
New England journal of medicine, 387(23), 2113-2125. Massachussetts Medical Society
Rohaan, M W, Borch, T H, Van Den Berg, J H, Met, Ö, Kessels, R, Geukes Foppen, M H, Stoltenborg Granhøj, J, Nuijen, B, Nijenhuis, C, Jedema, I, Van Zon, M, Scheij, S, Beijnen, J H, Hansen, M, Voermans, C, Noringriis, I M, Monberg, T J, Holmstroem, R B, Wever, L D V, Van Dijk, M, Grijpink-Ongering, L G, Valkenet, L H M, Torres Acosta, A, Karger, M, Borgers, J S W, Ten Ham, R M T, Retèl, V P, Van Harten, W H, Lalezari, F, Van Tinteren, H, Van Der Veldt, A A M, Hospers, G A P, Stevense-Den Boer, M A M, Suijkerbuijk, K P M, Aarts, M J B, Piersma, D, Van Den Eertwegh, A J M, De Groot, J W B, Vreugdenhil, G, Kapiteijn, E, Boers-Sonderen, M J, Fiets, W E, Van Den Berkmortel, F W P J, Ellebaek, E, Hölmich, L R, Van Akkooi, A C J, Van Houdt, W J, Wouters, M W J M, Van Thienen, J V, Blank, C U, Meerveld-Eggink, A, Klobuch, S, Wilgenhof, S, Schumacher, T N, Donia, M, Svane, I M & Haanen, J B A G 2022, ' Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma. ', New England Journal of Medicine, vol. 387, no. 23, pp. 2113-2125 . https://doi.org/10.1056/NEJMoa2210233Test
The New England journal of medicine, 387(23), 2113-2125. Massachussetts Medical Society
New England Journal of Medicine, 387(23), 2113-2125. MASSACHUSETTS MEDICAL SOCIETY
The New England Journal of Medicine, 387, 23, pp. 2113-2125مصطلحات موضوعية: Adoptive, Cell- and Tissue-Based Therapy, Outcomes, Dermatology, Metastatic melanoma, Guidelines, Immunotherapy, Adoptive, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], Lymphocytes, Tumor-Infiltrating, SDG 3 - Good Health and Well-being, Adoption, Humans, Melanoma/drug therapy, Lymphocytes, Tumor-Infiltrating, Melanoma, Skin Cancer, Treatments in Oncology, Cancer, General Medicine, Complete responses, Hematology/Oncology, Ipilimumab, n/a OA procedure, Adoptive cell therapy, Nivolumab, Ipilimumab/adverse effects, Immunotherapy
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edf28a71e5a16116e2b0f59cdac9485aTest
https://research.rug.nl/en/publications/9033fdbd-9e6f-4cca-a35b-50890da9f292Test -
2
المؤلفون: Irene L. M. Reijers, Alexander M. Menzies, Alexander C. J. van Akkooi, Judith M. Versluis, Noëlle M. J. van den Heuvel, Robyn P. M. Saw, Thomas E. Pennington, Ellen Kapiteijn, Astrid A. M. van der Veldt, Karijn P. M. Suijkerbuijk, Geke A. P. Hospers, Elisa A. Rozeman, Willem M. C. Klop, Winan J. van Houdt, Karolina Sikorska, Jos A. van der Hage, Dirk J. Grünhagen, Michel W. Wouters, Arjen J. Witkamp, Charlotte L. Zuur, Judith M. Lijnsvelt, Alejandro Torres Acosta, Lindsay G. Grijpink-Ongering, Maria Gonzalez, Katarzyna Jóźwiak, Carolien Bierman, Kerwin F. Shannon, Sydney Ch’ng, Andrew J. Colebatch, Andrew J. Spillane, John B. A. G. Haanen, Robert V. Rawson, Bart A. van de Wiel, Lonneke V. van de Poll-Franse, Richard A. Scolyer, Annelies H. Boekhout, Georgina V. Long, Christian U. Blank
المساهمون: Medical and Clinical Psychology, Oral and Maxillofacial Surgery, Medical Oncology, Radiology & Nuclear Medicine, Surgery, Guided Treatment in Optimal Selected Cancer Patients (GUTS)
المصدر: Nature Medicine, 28(6), 1178-+. NATURE PORTFOLIO
Nature Medicine, 28(6), 1178-1188. Nature Publishing Group
Nature Medicine
Nature medicine, 28(6), 1178-1188. Nature Publishing Group
Nature Medicine, 28. Nature Publishing Groupمصطلحات موضوعية: Skin Neoplasms, General Medicine, BIOMARKER ANALYSES, Ipilimumab, Neoadjuvant Therapy, General Biochemistry, Genetics and Molecular Biology, MORBIDITY, Nivolumab, QUALITY-OF-LIFE, Antineoplastic Combined Chemotherapy Protocols, Quality of Life, BIOPSY, SURVIVAL, Humans, AXILLARY, Neoplasm Recurrence, Local, IMMUNOTHERAPY, Melanoma, DISSECTION, SENTINEL LYMPH-NODE, Neoplasm Staging
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67d79d3cfe1f3c168f561afa30efdc6cTest
https://doi.org/10.1038/s41591-022-01851-xTest -
3
المؤلفون: Simone Brokamp, Annegien Broeks, Christian U. Blank, Petra Herzig, Marlous van den Braber, Daniela S. Thommen, Alfred Zippelius, Marjolein de Bruijn, Joyce Sanders, Ton N. Schumacher, Lisanne M. Roelofsen, Koen J. Hartemink, John B. A. G. Haanen, Kim Monkhorst, Paula Voabil, Sanne H. Hendriks
المصدر: Nature Medicine. 27:1250-1261
مصطلحات موضوعية: business.industry, medicine.medical_treatment, Cell, Cancer, General Medicine, Immunotherapy, medicine.disease, General Biochemistry, Genetics and Molecular Biology, Blockade, medicine.anatomical_structure, Immune system, Cell culture, medicine, Cancer research, Pd 1 blockade, business, Ex vivo
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::c45c19b51a9c099f12311a77da46c458Test
https://doi.org/10.1038/s41591-021-01398-3Test -
4
المؤلفون: Christian U. Blank, Rodabe N. Amaria, Jennifer A. Wargo, Bart A. van de Wiel, Georgina V. Long, Hussein Abdul-Hassan Tawbi, Alexander C. Huang, Xiaowei Xu, Richard A. Scolyer, Tara C. Mitchell, Giorgos C. Karakousis, Alexander C.J. van Akkooi, Michael A. Davies, Andrew J. Spillane, Elisa A. Rozeman, Alexander M. Menzies, Robyn P. M. Saw, Michael T. Tetzlaff, Ahmad A. Tarhini, Thomas E. Pennington, Elizabeth M. Burton, Paolo A. Ascierto, Serigne Lo
المصدر: Nature Medicine. 27:301-309
مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, business.industry, Surrogate endpoint, Melanoma, medicine.medical_treatment, Ipilimumab, General Medicine, Immunotherapy, medicine.disease, General Biochemistry, Genetics and Molecular Biology, Targeted therapy, Clinical trial, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Medicine, Nivolumab, business, Neoadjuvant therapy, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::826ffd3ff8235e1e6c027f5367069a0cTest
https://doi.org/10.1038/s41591-020-01188-3Test -
5
المؤلفون: A.C.J. van Akkooi, Judith M. Versluis, Christian U. Blank, Charlotte L. Zuur, Elisa A. Rozeman, Willem M.C. Klop, Esmée P. Hoefsmit, Lindsay G Grijpink-Ongering, María Jesús González González, Sandra Adriaansz, Robyn P. M. Saw, Sydney Ch'ng, Sten Cornelissen, J Stretch, Annegien Broeks, Ton N. Schumacher, A A Torres Acosta, Hanna Eriksson, Ron M. Kerkhoven, B.A. van de Wiel, Petros Dimitriadis, Richard A. Scolyer, Oscar Krijgsman, Daniel S. Peeper, J.B.A.G. Haanen, Omgo E. Nieweg, Karolina Sikorska, Kerwin F. Shannon, Georgina V. Long, W.J. van Houdt, A.M. Menzies, H. Mallo, Irene L.M. Reijers, Andrew J. Spillane
المصدر: Nature Medicine. 27:256-263
مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, business.industry, Melanoma, Phases of clinical research, Ipilimumab, General Medicine, medicine.disease, General Biochemistry, Genetics and Molecular Biology, law.invention, Clinical trial, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Randomized controlled trial, law, 030220 oncology & carcinogenesis, Internal medicine, medicine, Adjuvant therapy, Biomarker (medicine), Nivolumab, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::391917477f238f400900eee0200e3f22Test
https://doi.org/10.1038/s41591-020-01211-7Test -
6
المؤلفون: Paulien Kaptein, Celia Jacoberger-Foissac, Petros Dimitriadis, Paula Voabil, Marjolein de Bruijn, Simone Brokamp, Irene Reijers, Judith Versluis, Gahyathiri Nallan, Hannah Triscott, Elizabeth McDonald, Joshua Tay, Georgina V. Long, Christian U. Blank, Daniela S. Thommen, Michele W.L. Teng
المصدر: Science Translational Medicine, 14(642). AMER ASSOC ADVANCEMENT SCIENCE
مصطلحات موضوعية: Mice, Programmed Cell Death 1 Receptor, Animals, Humans, Interleukin-2, CTLA-4 Antigen, General Medicine, CD8-Positive T-Lymphocytes, Melanoma, Neoadjuvant Therapy
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6676795225993de96cda1c9757ccd80fTest
https://doi.org/10.1126/scitranslmed.abj9779Test -
7
المؤلفون: Elisa A. Rozeman, Judith M. Versluis, Ruben Moritz, Sofie Wilgenhof, Johannes V. van Thienen, John B.A.G. Haanen, Michel M. van de Heuvel, Christian U. Blank, Huub H. van Rossum
المصدر: Clinica chimica acta; international journal of clinical chemistry. 533
مصطلحات موضوعية: Skin Neoplasms, L-Lactate Dehydrogenase, Biochemistry (medical), Clinical Biochemistry, Programmed Cell Death 1 Receptor, General Medicine, S100 Calcium Binding Protein beta Subunit, Prognosis, Biochemistry, Antibodies, Biomarkers, Tumor, Humans, Prospective Studies, Melanoma, Retrospective Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6a442d4da402e3741825f223a108b67Test
https://pubmed.ncbi.nlm.nih.gov/35709988Test -
8
المؤلفون: Maurits L. van Montfoort, Daniel J. Vis, Kees Hendricksen, Nick van Dijk, Laura A. Smit, Michiel S. van der Heijden, Henk G. van der Poel, Maries van den Broek, Christian U. Blank, Annemarie Bruining, Yoni Lubeck, Lodewyk F. A. Wessels, Dennis Peters, Pia Kvistborg, Karina Silina, Ton N. Schumacher, Charlotte van Rooijen, Karolina Sikorska, Erik Hooijberg, Annegien Broeks, Bas W.G. van Rhijn, Alberto Gil-Jimenez, Jeantine M de Feijter, Thierry N. Boellaard
المساهمون: University of Zurich, van der Heijden, Michiel S, Graduate School
المصدر: Nature medicine, 26(12), 1839-1844. Nature Publishing Group
مصطلحات موضوعية: Adult, Male, 0301 basic medicine, medicine.medical_specialty, medicine.medical_treatment, Programmed Cell Death 1 Receptor, 610 Medicine & health, Ipilimumab, 10263 Institute of Experimental Immunology, Gastroenterology, General Biochemistry, Genetics and Molecular Biology, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, 1300 General Biochemistry, Genetics and Molecular Biology, Neoplasms, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, Humans, Medicine, CTLA-4 Antigen, Stage (cooking), Adverse effect, Aged, Neoplasm Staging, business.industry, Antibodies, Monoclonal, General Medicine, Immunotherapy, Middle Aged, Clinical trial, Nivolumab, 030104 developmental biology, 030220 oncology & carcinogenesis, Monoclonal, 570 Life sciences, biology, Female, Urothelium, business, medicine.drug
وصف الملف: 2020_van_Dijk_Nat_Med.pdf - application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0413d513e2c90df2d190163c39a4236dTest
http://www.scopus.com/inward/record.url?scp=85092396181&partnerID=8YFLogxKTest -
9
المؤلفون: Christian U. Blank, Roger S. Lo, Magdalena Thurin, Claus Garbe, Sanjiv S. Agarwala, Sandra Demaria, Iman Osman, Richard D. Carvajal, Ryan J. Sullivan, Thomas F. Gajewski, Giorgio Trinchieri, Hassane M. Zarour, Georgina V. Long, Marc S. Ernstoff, Igor Puzanov, Paolo A. Ascierto, Jason J. Luke, Reinhard Dummer, Michael A. Postow, Corrado Caracò, Bernard A. Fox, Soldano Ferrone, Janis M. Taube, Patrick Hwu
المصدر: Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-22 (2020)
Journal of Translational Medicineمصطلحات موضوعية: BRAF inhibitor, 0301 basic medicine, Oncology, medicine.medical_specialty, Electrochemotherapy, medicine.medical_treatment, lcsh:Medicine, Meeting Report, Anti-CTLA-4, Target therapy, General Biochemistry, Genetics and Molecular Biology, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Tumor Microenvironment, medicine, Adjuvant therapy, Humans, CTLA-4 Antigen, Melanoma, Adjuvant, Combination strategies, MEK inhibitor, Tumor microenvironment, business.industry, lcsh:R, General Medicine, Immunotherapy, medicine.disease, Combined Modality Therapy, Anti-PD-1, CAR-T, Radiation therapy, 030104 developmental biology, Italy, 030220 oncology & carcinogenesis, Neoadjuvant, business, Biomarkers
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::262f60d640e699b9c9d97a5cc4583ea7Test
http://link.springer.com/article/10.1186/s12967-020-02482-xTest -
10
المؤلفون: Michele W.L. Teng, Michael A. Postow, Reinhard Dummer, Claus Garbe, Paolo A. Ascierto, Christian U. Blank, Iman Osman, Michelle Krogsgaard, Patrick Hwu, Magdalena Thurin, Bernard A. Fox, Soldano Ferrone, Thomas F. Gajewski, Marc S. Ernstoff, Bart Neyns, Sergio A. Quezada, Igor Puzanov, Pawel Kalinski, Jason J. Luke, Roger S. Lo, Corrado Caracò, A. Testori, Giorgio Trinchieri
المساهمون: Clinical sciences, Medical Oncology, Laboratory of Molecular and Medical Oncology, University of Zurich, Ascierto, Paolo A
المصدر: Journal of Translational Medicine
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-18 (2021)مصطلحات موضوعية: 0301 basic medicine, Oncology, BRAF inhibitor, medicine.medical_specialty, medicine.medical_treatment, 610 Medicine & health, Genetics and Molecular Biology, Translational research, Meeting Report, Anti-CTLA-4, Target therapy, General Biochemistry, Genetics and Molecular Biology, Targeted therapy, 03 medical and health sciences, 0302 clinical medicine, 1300 General Biochemistry, Genetics and Molecular Biology, Internal medicine, medicine, Melanoma, Adjuvant, Combination strategies, Tumor microenvironment, MEK inhibitor, business.industry, 10177 Dermatology Clinic, General Medicine, medicine.disease, Precision medicine, Immune checkpoint, Anti-PD-1, 030104 developmental biology, 030220 oncology & carcinogenesis, General Biochemistry, oncology, Biomarker (medicine), Medicine, Immunotherapy, Neoadjuvant, business, Biomarkers
وصف الملف: 910_Ascierto_PA._et_al._Perspectives_in_Melanoma_meeting_report_from_the_Melanoma_Bridge_(December_3rd-5th,_2020,_Italy)_J_Transl_Med_2021.pdf - application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::728ae34e331a3034551bf810df26f0f3Test
http://europepmc.org/articles/PMC8243582Test